US Bancorp’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

US Bancorp’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-2,581	Closed	-$112K	–	3824
2015 Q3	$112K	Sell	2,581 -22	-0.8%	-$928	﹤0.01%	2022
2015 Q2	$110K	Sell	2,603 -64	-2%	-$2.7K	﹤0.01%	2092
2015 Q1	$103K	Buy	2,667 +127	+5%	+$4.89K	﹤0.01%	2148
2014 Q4	$86K	Sell	2,540 -998	-28%	-$35.2K	﹤0.01%	2244
2014 Q3	$124K	Sell	3,538 -277	-7%	-$9.49K	﹤0.01%	1998
2014 Q2	$126K	Buy	3,815 +49	+1%	+$1.68K	﹤0.01%	2015
2014 Q1	$138K	Buy	3,766 +20	+0.5%	+$734	﹤0.01%	1949
2013 Q4	$144K	Buy	+3,746	New	+$118K	﹤0.01%	1907

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

US Bancorp's WX Position: Q4 2015 in Review

US Bancorp sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 2,581 shares — an estimated $112K sold.

US Bancorp first reported a position in WX in Q4 2013 and held it in 8 quarters. The position peaked at $144K in Q4 2013. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

US Bancorp reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
US Bancorp sold 2,581 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $112K.
US Bancorp first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2013 and held it in 8 quarters.
US Bancorp's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $144K in Q4 2013.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on US Bancorp's 13F filing for Q4 2015, filed 10 Feb 2016.